Firdapse 10 MG tablet 10S
Ended Awarded
- Contract number
- SPE2DX25F6AGM
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $28,467
Award facts
- Contract value 100% obligated
- $28,467.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Logistics Agency (DLA) awarded a delivery order valued at $28,467.19 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on September 22, 2025. The contract calls for the delivery of Firdapse 10 mg tablets (10 count) with an ultimate completion date of October 14, 2025. This award utilizes a firm fixed-price structure with no set-aside designation and represents a single delivery order under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA.
DMS Pharmaceutical Group holds a significant $499.9 billion Indefinite Delivery Contract with the DLA under the SPE2DB program, which remains valid through November 2026 and serves as the vehicle for issuing delivery orders like this one. The company specializes in distributing branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare facilities nationwide. Firdapse (amifampridine) is a specialty pharmaceutical product used in the treatment of Lambert-Eaton myasthenic syndrome, reflecting the company's role in supplying specialized medications to military health facilities. This delivery order exemplifies the operational execution of the broader IDC framework that enables the DLA to efficiently procure pharmaceutical products supporting federal healthcare supply chain needs.
Quick answers
Who was awarded contract SPE2DX25F6AGM?
SPE2DX25F6AGM was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 22, 2025.
How much is contract SPE2DX25F6AGM worth?
The government has obligated $28,467 on SPE2DX25F6AGM.
Is contract SPE2DX25F6AGM an order under another contract?
Yes. SPE2DX25F6AGM is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F6AGM competed?
The extent of competition for SPE2DX25F6AGM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award